AXXE Financials 07/15/2014 22:04:30 Axxess Pharma
Post# of 151
Posted On: 07/15/2014 11:04:27 PM
AXXE Financials 07/15/2014 22:04:30
Axxess Pharma, Inc.
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development - -
Sales, General and Admin. 187 78
Non-Recurring Items - -
Other - -
Operating Income (187) (78)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (187) (78)
Interest Expense 18 -
Earnings Before Tax (205) (78)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (205) (78)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (205) (78)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (205) (78)
Axxess Pharma, Inc.
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development - -
Sales, General and Admin. 187 78
Non-Recurring Items - -
Other - -
Operating Income (187) (78)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (187) (78)
Interest Expense 18 -
Earnings Before Tax (205) (78)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (205) (78)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (205) (78)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (205) (78)
(0)
(0)Allstar Health Brands Inc (ALST) Stock Research Links
Scroll down for more posts ▼